Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy

J Antimicrob Chemother. 2013 Aug;68(8):1938-9. doi: 10.1093/jac/dkt095. Epub 2013 Mar 27.
No abstract available

Keywords: antiretrovirals; cord blood concentrations; pharmacokinetics; virological failure; ws gIQ.

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Antiretroviral Therapy, Highly Active / methods
  • Cyclohexanes / administration & dosage
  • Cyclohexanes / pharmacokinetics*
  • Darunavir
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Maraviroc
  • Nitriles
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pyridazines / administration & dosage
  • Pyridazines / pharmacokinetics*
  • Pyrimidines
  • RNA, Viral / blood
  • Sulfonamides / administration & dosage
  • Treatment Failure
  • Triazoles / administration & dosage
  • Triazoles / pharmacokinetics*
  • Viral Load

Substances

  • Anti-HIV Agents
  • Cyclohexanes
  • Nitriles
  • Pyridazines
  • Pyrimidines
  • RNA, Viral
  • Sulfonamides
  • Triazoles
  • etravirine
  • Maraviroc
  • Darunavir